1.8900
+0.0200
+(1.07%)
At close: January 24 at 4:00:02 PM EST
1.7899
-0.10
(-5.30%)
After hours: 7:55:45 PM EST
Insider Purchases Last 6 Months
Shares | Transactions | |
---|---|---|
Purchases | 235,500 | 3 |
Sales | 61 | 1 |
Net Shares Purchased (Sold) | 235,439 | 4 |
Total Insider Shares Held | 141.02k | -- |
% Net Shares Purchased (Sold) | -249.40% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
Shares | |
---|---|
Net Shares Purchased (Sold) | -- |
% Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
Insider | Transaction | Type | Value | Date |
---|---|---|---|---|
HERSKOWITZ NEIL Director | Sale at price 2.00 per share. | Direct | 46 | Dec 2, 2024 |
KRANZLER JAY D Director | Sale at price 2.24 per share. | Direct | 137 | Nov 5, 2024 |
KRANZLER JAY D Director | Purchase at price 2.40 - 2.50 per share. | Direct | 1,250 | Sep 30, 2024 |
MACLEAN ALEXANDRA M.D. Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Sep 23, 2024 |
JIN DAVID Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Sep 23, 2024 |
FORTRESS BIOTECH, INC. Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Apr 16, 2024 |
FORTRESS BIOTECH, INC. Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 2, 2024 |
DAVIDOW ROBERT L Beneficial Owner of more than 10% of a Class of Security | Sale at price 0.14 - 0.15 per share. | Indirect | 86,560 | Dec 11, 2023 |
ROSENWALD LINDSAY A Director | Purchase at price 0.72 per share. | Direct | 251,046 | Sep 8, 2023 |
FORTRESS BIOTECH, INC. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 0.72 per share. | Direct | 301,255 | Sep 8, 2023 |
FORTRESS BIOTECH, INC. Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 31, 2023 |
Related Tickers
QNRX Quoin Pharmaceuticals, Ltd.
0.3809
-7.41%
EVAX Evaxion Biotech A/S
6.03
+773.91%
VIGL Vigil Neuroscience, Inc.
2.2000
-0.90%
ELAB PMGC Holdings Inc.
3.1000
+273.49%
BTAI BioXcel Therapeutics, Inc.
0.3400
-9.96%
RNAZ TransCode Therapeutics, Inc.
7.04
+81.98%
HEPA Hepion Pharmaceuticals, Inc.
0.1906
-2.36%
CDIO Cardio Diagnostics Holdings, Inc.
0.4594
-13.32%
XCUR Exicure, Inc.
12.02
-17.37%
DRMA Dermata Therapeutics, Inc.
1.1700
+0.86%